# Glycemic Response to Momordica Charantia in Type 2 Diabetes

> **NCT00823953** · PHASE2 · WITHDRAWN · sponsor: **Services Hospital, Lahore**

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Momordica charantia
- **OTHER:** starch powder

## Key facts

- **NCT ID:** NCT00823953
- **Lead sponsor:** Services Hospital, Lahore
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-11
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** IP could not be made available in sufficient quantity for the expected enrollment
- **Last updated:** 2012-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823953, "Glycemic Response to Momordica Charantia in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00823953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*